Ikarian Capital’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,831
| Closed | -$59K | – | 105 |
|
|
2022
Q2 | $59K | Sell |
26,831
-711,541
| -96% | -$1.56M | 0.01% | 94 |
|
|
2022
Q1 | $2.32M | Buy |
738,372
+33,290
| +5% | +$105K | 0.3% | 36 |
|
|
2021
Q4 | $2.26M | Sell |
705,082
-400,000
| -36% | -$1.28M | 0.34% | 36 |
|
|
2021
Q3 | $3.72M | Sell |
1,105,082
-19,790
| -2% | -$66.5K | 0.26% | 36 |
|
|
2021
Q2 | $4.4M | Hold |
1,124,872
| – | – | 0.36% | 37 |
|
|
2021
Q1 | $4.52M | Buy |
+1,124,872
| New | +$4.52M | 0.15% | 49 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 174 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 141 |
|
|
2020
Q2 | – | Sell |
-377,737
| Closed | -$1.13M | – | 122 |
|
|
2020
Q1 | $1.13M | Buy |
377,737
+27,737
| +8% | +$82.7K | 0.08% | 48 |
|
|
2019
Q4 | $1.45M | Buy |
+350,000
| New | +$1.45M | 0.24% | 24 |
|